Melitrix operates an integrated platform spanning specialty pharmaceuticals, generics, consumer health, development consulting, and CDMO manufacturing. Owning the whole chain lets a program move from idea to market without losing momentum between vendors.
Differentiated therapies developed on the 505(b)(2) pathway, reformulations and combinations that leverage existing safety data to reach patients faster, with a clear clinical rationale behind every program.
A pipeline of bioequivalent generic products across sterile injectables, oral liquids, and oral solids, developed with our R&D partners and manufactured through an established European network.
Our first consumer health range, color cosmetics and nutraceuticals developed to pharmaceutical quality standards and built for distribution across regulated and emerging markets.
We do for other companies what we do for our own pipeline, regulatory strategy, formulation development, and the work of getting a product into a new market, without them building the function in-house.
Access to dedicated European manufacturing capacity and a vetted network of development, manufacturing, and distribution partners across Europe, India, and emerging markets.
A snapshot of our active programs. Product and indication-specific details are shared with qualified partners under confidentiality.
Program names are internal designations. Stages are indicative and subject to change.
Our platform is built to navigate the range of pathways relevant to our products, without compromise on scientific or procedural rigor.
Hybrid NDA pathway that leverages existing safety data for reformulated, repurposed, or combination drug products.
Abbreviated new drug application for bioequivalent generic therapies referencing an approved innovator product.
Good manufacturing practice standards, both European and WHO, governing our sterile, liquid, and solid-dose partner sites across regulated and emerging markets.
Cosmetic (MoCRA / EU CPR) and dietary supplement frameworks governing our consumer health range across markets.
Tell us what you are working on, a program, a product, a market, and we will point you to the right part of the platform.